Albumin Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Human Serum Albumin, Bovine Serum Albumin, and Recombinant Albumin), By Application (Drug Formulation and Vaccines, Life Sciences, Culture Media Ingredient, and Others), By Distribution Channel (Biopharmaceutical and Biotechnology Companies, Academic Research Institutes, and Others) and Region    

Albumin Market size was valued at US$ 6,641 million in 2024, growing at a CAGR of 10.2% from 2024-2030. Albumins belong to the family of globular proteins. All the proteins present in the albumin family are water-soluble and moderately soluble in concentrated salt solutions. When subjected to heat, undergo denaturation. The albumins contribute 50% to 60% of the blood plasma proteins. The most common of them is serum albumins. The human serum albumin is the most abundant protein in human blood plasma. In March 2016, CSL Behring announced that the U.S. Food and Drug Administration (FDA) has approved IDELVION [Coagulation Factor IX (Recombinant), Albumin Fusion Protein], its novel, long-acting albumin fusion protein linking recombinant coagulation factor IX with recombinant albumin for the treatment of hemophilia B.

The global Albumin Market research report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland, and the Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezuela, and Rest of Latin America), and the Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of the Middle East and Africa).